PT - JOURNAL ARTICLE AU - Brennan H. Baker AU - Heather H. Burris AU - Tessa R. Bloomquist AU - Amélie Boivin AU - Virginie Gillet AU - Annie Larouche AU - Jean-Philippe Bellenger AU - Jean-Charles Pasquier AU - Andrea A. Baccarelli AU - Larissa Takser TI - Prenatal Acetaminophen, Adverse Birth Outcomes, and ADHD: Mediation Analysis in a Prospective Cohort AID - 10.1101/2021.06.08.21258568 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.08.21258568 4099 - http://medrxiv.org/content/early/2021/06/11/2021.06.08.21258568.short 4100 - http://medrxiv.org/content/early/2021/06/11/2021.06.08.21258568.full AB - Background Although we previously reported an association of prenatal acetaminophen exposure with more than two-fold increased odds of child ADHD, it is unknown whether prenatal acetaminophen is associated with adverse birth outcomes, and if birth outcomes may mediate the association of prenatal acetaminophen with ADHD.Methods This birth cohort from Sherbrooke, Québec, Canada, included 773 live births. Mothers with no thyroid disease enrolled at their first prenatal care visit or delivery. Acetaminophen was measured in meconium for 393 children at delivery. Physician diagnosis of ADHD was determined when children were 6-7 years old. We first tested associations of prenatal acetaminophen with birthweight, preterm birth, gestational age, and small and large for gestational age. Then we assessed whether these birth outcomes mediate the association of prenatal acetaminophen with ADHD. We imputed missing data via multiple imputation and used inverse probability weighting to account for confounding and selection bias.Results Acetaminophen was detected in 222 meconium samples (56.5%). Prenatal acetaminophen exposure was associated with decreased birthweight by 136 grams (β = -136; 95%CI [-229, - 43]), 20% increased weekly hazard of delivery (hazard ratio = 1.20; 95%CI [1.00, 1.43]), and over 60% decreased odds of being born large for gestational age (odds ratio = 0.38; 95%CI [0.20, 0.75]). There was no evidence for adverse birth outcomes mediating the association of prenatal acetaminophen with child ADHD.Conclusions Although unobserved confounding and confounding by indication are possible, these results warrant further investigation into adverse perinatal effects of prenatal acetaminophen exposure.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institute of Environmental Health Sciences (R21ES024841, R01ES027845) and the Canadian Institutes of Health Research (MOP-84551). This work was also supported by a Canadian Research Chair (CRC-950-230570) Grant from the Natural Sciences and Engineering Research Council of Canada.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All study protocols were approved by the institutional review boards of the University of Sherbrooke and Columbia University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData contain protected health information and are thus confidential. Code used for the analyses are available upon request.